HOME >> MEDICINE >> NEWS
Molecular tailoring of chemotherapy with novel imaging techniques

(Philadelphia, PA) Researchers at the Abramson Cancer Center of the University of Pennsylvania are applying a host of imaging techniques to develop better ways to look noninvasively at the molecular characteristics of tumors. The experiments, now in human cell cultures and mouse models, are aimed at better forecasting early response to chemotherapy so that treatment choices can be adjusted.

"Right now in cancer therapy, with the exception of relatively uncommon examples of cancers for which we have tumor markers, we don't have reliable ways of predicting who is going to respond early on to chemotherapy," says Wafik El-Deiry, MD, PhD, Associate Professor, Departments of Medicine, Genetics, and Pharmacology. "Currently cancer patients get their chemo and you can't tell if they're responding for several weeks. We need to have tests that will tell us if patients are going to respond to the chemo or the radiation soon after it's first given, and whether these responses are going to last."

Two recent papers in Cancer Biology & Therapy and Cancer Research describe the work of the El-Deiry laboratory. One approach is to use a molecular beacon, a molecule that can be activated within cells due to a specific context, such as in this case, the response to chemotherapy. The beacon recognizes a characteristic change in chemo-treated tumor cells, physically opens up and fluoresces, which can then be measured. "The beacon goes right into the living cell and if it opens up, emitting fluorescence, we can detect the glow," says El-Deiry.

Human lung-cancer cells were treated with the chemotherapeutic agent doxorubicin (Adriamycin), which causes cellular DNA damage. Doxorubicin works through the tumor suppressor protein p53, which ultimately kills many types of cancer cells. "We engineered a molecular beacon to detect expression of a gene called p21, that is turned on directly by p53 when cells are exposed to Doxorubicin," says El-Deiry.

The cells
'"/>

Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine
1-Dec-2004


Page: 1 2 3 4

Related medicine news :

1. Molecular test predicts risk of breast cancer recurrence and who will benefit from chemotherapy
2. Jefferson and Molecular Targeting Technologies, Inc. scientists create vaccine for wildlife rabies
3. Molecular clock genes influence metabolism of sugar and dietary fats
4. Data announced at ISHLT: Molecular testing proves effective in monitoring heart transplant rejection
5. Molecular analyses of leukemia patients suggest strategies for better treatments
6. Molecular test proves to be effective in measuring remission and relapse after cancer treatment
7. Molecular tag pinpoints which breast cancer tumors are most likely to spread
8. Molecular mechanism underlaying anthrax infection described by UCSD School Of Medicine researchers
9. Molecularly targeted drug slows tumor growth in patients
10. Molecular self-assembly techniques used to coat biomedical substrates
11. Molecular nanogenerator developed that can target cancer cells and destroy them

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/21/2020)... ... May 21, 2020 , ... ... Clinical Research, CenterWatch eLearning , https://www.centerwatch.com/products/category/2764-elearning/product/472-the-crc-trainer , Wherever one falls ... Companion to the CRC’s Guide to Coordinating Clinical Research provides the perfect ...
(Date:5/21/2020)... ... May 21, 2020 , ... A Safe Haven Foundation (ASHF) has ... $5 million AbbVie COVID-19 Community Resilience Fund. The fund was created in March to ... frontline homeless workers in service to vulnerable populations in hard-hit communities. , “We ...
(Date:5/21/2020)... Mass. (PRWEB) , ... May 21, 2020 , ... ... of its award-winning population health management platform that supports care management and utilization ... than 100 individuals at client sites, TruCare 2020 provides significant usability and automation ...
(Date:5/16/2020)... CHARLOTTE, N.C. (PRWEB) , ... May 15, 2020 , ... On May 21, T1V will ... of the Ellison Institute of USC, and a contributor to CBS news, as we address ... been in place in most parts of the country since March, many questions are left ...
(Date:5/15/2020)... , ... May 15, 2020 , ... ... management solutions, recently announced the company and its healthcare-focused background screening division, PreCheck, ... 10 Pre-Employment Screening Consulting/Services Companies 2020. A distinguished panel comprising of CEOs, CIOs, ...
Breaking Medicine News(10 mins):
(Date:5/21/2020)... ... May 21, 2020 , ... Latham Pool Products Aids I2m ... polymer film gowns that will be worn by doctors and nurses , Latham ... accessories, is excited to give back to the community in a collaborative effort ...
(Date:5/21/2020)... ... 2020 , ... After The World Health Organization officially declared ... to continue seeing patients despite lockdowns and stay at home orders. According to ... complete healthcare communications, conducted online by The Harris Poll among more than 2,000 ...
(Date:5/21/2020)... ... ... Cataract is the world's leading cause of blindness , accounting for approximately ... more than 25 million Americans are estimated to have cataract, according to the report ... the population in America continues to age, the number of cataract cases are projected ...
Breaking Medicine Technology:
Cached News: